What is the intellectual property policy for an AMI?
An AMI operates as a non-profit 501(c)(3) private operating foundation on a university’s campus. Under the terms of the Affiliation Agreement between the university and the AEMFBE, the AMI has the right to review and request adoption of specific biomedical intellectual property disclosed to the Technology Transfer Office, unless the biomedical technology is already licensed to another party. The researchers at the partnering universities have the option to negotiate with an alternate outside entity other than their Alfred Mann Institute if preferred. The university owns the intellectual property created by their researchers. The AMI acquires a global, sole, exclusive, royalty-free (on the front-end) license from the university. In the licensing negotiation phase, many aspects are agreed upon between the AEMFBE and the university, such as jointly discovered technologies, licensing a patent portfolio, background intellectual property, milestones, etc.
